ProfileGDS5822 / ILMN_2614861
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 67% 45% 65% 52% 51% 63% 56% 46% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 140.867
GSM1276600PDAC Late Ablation Control 221.945
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 132.565
GSM1276603PDAC Late Ablation 224.452
GSM1276604PDAC Late Ablation 325.151
GSM1303940PDAC Late Ablation_anti-CTLA4 132.163
GSM1303941PDAC Late Ablation_anti-CTLA4 230.356
GSM1303942PDAC Late Ablation_anti-CTLA4 323.246